Meridian Bioscience Inc: Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
Read the official notice at FDA (device) →
Get alerts for Meridian Bioscience
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Meridian Bioscience Inc
- Product
- Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
- Reason / hazard
- The affected lots show a decline in performance over time, which may lead to false-negative results.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- US Nationwide distribution and the OUS country of Italy.
- Recall initiated
- 2025-12-05
- Code info
- UDI-DI: 00840733102349; Lot Numbers: 410300U195, 410300U196, 410300U197, 410300U201
- Product quantity
- 211 units
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Cincinnati
- State
- OH
- Country
- United States
- Event id
- 98038
Free daily digest + "My products" watchlist